ASAM Provider Guide

National Practice Guideline

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1019954

Contents of this Issue

Navigation

Page 21 of 23

Table 8. Summary of Special Population Recommendations Condition Testing Psychosocial Rx Agonist Rx Pregnancy HIV; hepatitis A, B, and C; STD testing and prevention, urine drugs Methadone or buprenorphine monoproduct a Pain HIV; hepatitis A, B, and C; STD testing and prevention, urine drugs Methadone or buprenorphine Adolescents HIV; hepatitis A, B, and C; STD testing and prevention, urine drugs Methadone or buprenorphine Psychiatric Disorders HIV; hepatitis A, B, and C; STD testing and prevention, urine drugs; suicide potential Methadone or buprenorphine Incarceration HIV; hepatitis A, B, and C; STD testing and prevention, urine drugs Methadone or buprenorphine a e guidelines specifically promote buprenorphine monotherapy. Treatment 20

Articles in this issue

Archives of this issue

view archives of ASAM Provider Guide - National Practice Guideline